The infectious lung disease TB was the top two global killer in 2022 after COVID-19. The highest rates were in South Asia.An estimated 10.6 million people developed tuberculosis (TB) in 2022.
To prevent the reactivation of latent tuberculosis infection during anti-TNF therapy, clinicians should screen all patients for tuberculosis, and begin treatment if latent infection is found ...
Certainly, the study suggests that tuberculosis and some other granulomatous infections are likely to occur more frequently among patients treated with infliximab than among those treated with ...
Both of these diseases can be caused by a variety of infectious agents. Deaths from the infectious diseases HIV/AIDS and tuberculosis have fallen significantly in recent years, and they no longer ...
Tuberculosis is a communicable disease caused by infection with the tubercle bacillus (also known as Mycobacterium tuberculosis or M. tuberculosis), most frequently affecting the lungs.
Drug-resistant infections occur when pathogens change in ways that render antimicrobial drugs ineffective. As a result, the pathogens survive and continue to spread. When infections are treatable with ...
Emerging infectious diseases are infections that have recently appeared within a population or those whose incidence or geographic range is rapidly increasing or threatens to increase in the near ...
tuberculosis in the murine lung Mycobacterium tuberculosis infection remains a global health crisis. Here researchers characterise the alveolar macrophage subsets in a murine model of BCG ...
There is an increasing amount of research into the link between certain infections and dementia, including herpes, pneumonia, syphilis, Lyme disease and gum disease. Research shows that dementia is ...
health officials grapple with an early COVID-19 infection spike and higher-than-normal tuberculosis infections in Wyandotte County. COVID positivity rates have been steadily increasing in Kansas ...
In 2018, India set for itself the lofty goal of eliminating pulmonary tuberculosis (TB ... 47% of people who developed multi-drug resistant infection which is unresponsive or resistant to at ...